Emily G McDonald
Awards & Honours
0
Awards Won
3
Honours
2
Records
Emily G. McDonald stands as one of the most cited researchers in clinical epidemiology and pharmacology in Canada. Her work on deprescribing has fundamentally shifted how North American healthcare systems approach medication management for the elderly. Being selected to lead the CADeN network places her at the helm of a critical national initiative, highlighting her trusted status among peers. Her recent 2026 study in the New England Journal of Medicine marks a historic contribution to infectious disease treatment, offering a scalable solution to a persistent medical challenge.
Honours & Distinctions
Associate Professor of Medicine
Promotion to senior academic rank recognizing significant research output and teaching excellence.
Director of CADeN
Leadership appointment to coordinate national deprescribing research efforts.
Chief Medical Officer
Executive appointment overseeing medical strategy for AI-driven health technology.
Records & Feats
High Citation Count in Clinical Epidemiology
Accumulated over 11,000 citations on Google Scholar, marking her as a top authority in medication safety.
NEJM Breakthrough on C. Difficile Prevention
Led the publication of a landmark study in the New England Journal of Medicine demonstrating a novel vancomycin regimen.